Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Intra-Tumoral Injections of Ex Vivo Expanded Natural Killer Cells in Children and Young Adults With Recurrent or Progressive Malignant Brain Tumors

NCT05887882 is registered in ClinicalTrials.gov with Sabine Mueller, MD, PhD as lead sponsor.

NCT NCT05887882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05887882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Intra-Tumoral Injections of Ex Vivo Expanded Natural Killer Cells in Children and Young Adults With Recurrent or Progressive Malignant Brain Tumors
Lead sponsor
Sabine Mueller, MD, PhD
Phase
Phase 1
Overall status
Suspended
Start date
May 31, 2024
Completion date
December 31, 2027
Enrollment
24 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric brain tumor, pediatric neoplasm, recurrent pediatric brain tumor